M&A & Deal Consolidation ▲ Uptick
$380M+ +14% vs 4-wk avg
Tuck-in acquisitions surging in smart navigation, catheter sensor arrays, and interventional robotics platforms.
Context: Historical median: $310M
Week of October 5 News
Weekly Clearances, Regulatory Enforcement, Market Trends & AI In MedTech
Executive Takeaway · 2-Minute Read
Clearance activity centers on three archetypes: (1) energy-based platform expansion with Ultima System UL-800 plus Ultimate Face Package UL-800-Face-Set and Ultimate Shape Extension Kits 1 and 2, (2) minimally invasive spinal fixation with Kentrospine Viktr-MIS Pedicle Screw System, (3) safety-engineered vascular access with Profoject Safety Sliding Blood Collection Set. Pattern indicates continued FDA throughput for modular line extensions rather than de novo novel mechanisms, with emphasis on anatomical expansion, procedural efficiency, and sharps-risk mitigation.
Regulatory Signal 510(k) & Software
High clearance throughput for neurostimulators and 3D dosimetry algorithms, with CDRH triage favoring modular predicate equivalence.
Quality Enforcement Sterility & QMS
Class II packaging and endotoxin recalls highlight urgent supplier quality controls and ASTM F88 seal validation audits.
Commercial Shift Electrophysiology
Pulsed Field Ablation (PFA) captures 42% of new EP installs, forcing legacy RF and cryoablation platforms into defensive discounting.
Engineering Action Premarket Cyber
Section 524B SBOM refusals continue at 40%+; engineering teams must embed machine-readable vulnerability exports into Phase 2 design controls.
New 510(k) Clearances
47 +8% vs 4-wk avg
Neuromodulation & Surgical leading Safety & Recalls
8 Sterility & Material drift
CDRH Class II Enforcement Key M&A & Funding
$380M+ Strategic Consolidation
Robotics & Navigation platforms Fastest Growing Sector
PFA & Neuro +34% YoY Volume
Pulsed Field Ablation surge 
Macro Trajectory & Velocities
Upticks & Downticks Across the Industry
Weekly directional shifts across regulatory throughput, M&A deal consolidation, quality enforcement actions, and early-stage capital allocation.
510(k) Clearance Flow ▲ Uptick
47 Clearances +8% vs 4-wk avg
CDRH clearance velocity high for neuromodulation & surgical tools; eSTAR triage medians down to 118 review days.
Context: Historical median: 42 / week
Enforcement & Recalls ▼ Downtick
8 Class II Actions -12% vs 4-wk avg
Packaging seal breaches and raw material pyrogen variability dominate root causes, while firmware recalls stabilize.
Context: Historical median: 10 / week
Venture & Non-Dilutive Capital ► Stable
$140M Allocated +2% YoY
Private early-stage rounds remain selective, but NIH SBIR/STTR and ARPA-H non-dilutive grant participation is up 28%.
Context: SBIR Phase II median: $2.0M
Procedural & Market Growth
Growth Velocity by MedTech Sector
Comparative annual expansion rates across major medical technology verticals. High-volume hospital cath labs and ambulatory surgery centers drive disproportionate share toward non-thermal and robotic platforms.
01
510(k) Clearance & Submission Radar
Notable FDA 510(k) clearances and predicates for 2026-W41.
K260945 Procode:
2026-09-27 Ultima System (UL-800);Ultimate Face Package (UL-800-Face-Set);Ultimate Shape Extension Kit 1 (UL-800-Shape-Ext-Kit-1);Ultimate Shape Extension Kit 2 (UL-800-Shape-Ext-Kit-2)
Applicant: Fit-Pro KFT (Ltd.) - DBA E-Fit
510(k) clearance granted under product code . Indications cover prescription clinical usage.
Engineering & Regulatory Takeaway:
Benchmark against predicate product code ; verify testing matrix covers all clinical endpoints in FDA summary guidance.
K252139 Procode: NKB
2026-09-27 Kentrospine Viktr-MIS® Pedicle screw system
Applicant: Rivarp Medical Pvt., Ltd.
510(k) clearance granted under product code NKB. Indications cover prescription clinical usage.
Engineering & Regulatory Takeaway:
Benchmark against predicate product code NKB; verify testing matrix covers all clinical endpoints in FDA summary guidance.
K262215 Procode: JKA
2026-09-25 Profoject Safety Sliding Blood Collection Set
Applicant: CMT Health PTE., Ltd.
510(k) clearance granted under product code JKA. Indications cover prescription clinical usage.
Engineering & Regulatory Takeaway:
Benchmark against predicate product code JKA; verify testing matrix covers all clinical endpoints in FDA summary guidance.
K254291 Procode: GDW
2026-09-25 easyEndo E-Lite Single Use Powered Endoscopic Staplers; easyEndo E-Lite Single Use Powered Endoscopic Staplers with Curved Tip; easyEndo E-Lite Single Use Cartridges
Applicant: Ezisurg Medical Co., Ltd.
510(k) clearance granted under product code GDW. Indications cover prescription clinical usage.
Engineering & Regulatory Takeaway:
Benchmark against predicate product code GDW; verify testing matrix covers all clinical endpoints in FDA summary guidance.
K254058 Procode: DRT
2026-09-25 DistaSense(TM) (v1)
Applicant: Life Detection Technologies
510(k) clearance granted under product code DRT. Indications cover prescription clinical usage.
Engineering & Regulatory Takeaway:
Benchmark against predicate product code DRT; verify testing matrix covers all clinical endpoints in FDA summary guidance.
K254230 Procode: QZF
2026-09-25 CapsoView (CVV); CapsoCloud (CLD)
Applicant: CapsoVision, Inc.
510(k) clearance granted under product code QZF. Indications cover prescription clinical usage.
Engineering & Regulatory Takeaway:
Benchmark against predicate product code QZF; verify testing matrix covers all clinical endpoints in FDA summary guidance.
02
De Novo Classifications & Class III (PMA) Radar
Novel regulatory classifications and Class III approvals.
DEN240018 De Novo Classification 21 CFR 882.1640
2026-09-08 AcuTrac Intraoperative Microvascular Perfusion Sensor
Sponsor: NeuroPulse Bioengineering
First-of-a-kind non-invasive laser speckle contrast imaging platform providing real-time quantitative capillary perfusion mapping during cranial microvascular clipping and bypass procedures.
Pathway & Clinical Impact:
Creates a brand new Class II regulatory pathway with special controls requiring laser safety verification (IEC 60825-1), thermal drift mitigation, and intraoperative ambient light suppression.
P240032 PMA Approval (Class III) 21 CFR 870.3360
2026-09-02 BioMatrix Coronary Bioadaptor Scaffold System
Sponsor: Elixir Medical Corporation
Class III sirolimus-eluting coronary scaffold engineered with uncaging mechanism that unlocks vessel motion, pulsatility, and adaptive remodeling after 6 months of strut resorption.
Pathway & Clinical Impact:
Demonstrated statistically superior vessel compliance preservation versus standard drug-eluting stents (DES) in randomized trials; requires 5-year post-approval patient registry.
03
Breakthrough Hardware: Physical Product Teardowns
Studio macro photography, materials science callouts, and design failure modes for newly cleared physical platforms.
Electrophysiology & Interventional Cardiology Class II / Class III Catheter System
Steerable Multi-Electrode Pulsed Field Ablation (PFA) Catheter
Anatomically conformable circular multi-electrode array delivering microsecond non-thermal irreversible electroporation pulses to pulmonary vein ostia.
8.5 Fr Outer DiameterPt/Ir Ring Electrodes (2.0 kV)Braided Pebax ShaftDual Pull-Wire Steerable
Photo: Macro studio teardown of articulating 8.5 Fr PFA catheter tip featuring micro-irrigation laser pores and Pt/Ir ring electrodes.
Architectural Specifications
- French Size:
- 8.5 Fr (2.83 mm OD)
- Shaft Construction:
- Pebax 72D/55D composite + 304V SS braid (65 PPI)
- Electrode Array:
- Platinum-Iridium (90/10), 4–8 ring configuration
- Inner Liner:
- Etched PTFE 0.0005″ wall thickness
- Pulse Waveform:
- Biphasic symmetrical, 1.8–2.0 kV amplitude
Design & Verification Methodology:
Model-Based Deflection & Finite Element Electric Field Modeling (COMSOL) to optimize cardiac lesion depth without phrenic nerve thermal collateral damage.
Critical Quality & Verification Failure Modes:
- ASTM F88 / F2096 sterile barrier puncture from rigid electrode array tips during transit
- Dielectric breakdown of polyimide insulation under 2 kV peak pulse voltages
- Pull-wire fatigue fracture at proximal steering ring after 500+ articulation cycles
Neurology & Microvascular Surgery De Novo Class II (DEN240018)
AcuTrac Intraoperative Microvascular Perfusion Sensor
Handheld laser speckle contrast optical probe providing continuous real-time quantitative capillary blood flow maps during cerebral aneurysm clipping.
Ti-6Al-4V Enclosure785 nm NIR Laser Diode15–30 mm Working DistanceIPX8 Hermetic
Photo: Handheld hermetic Ti-6Al-4V laser speckle contrast probe configured with 785 nm NIR diode for intraoperative microvascular imaging.
Architectural Specifications
- Illumination:
- 785 nm single-mode NIR laser diode (Class 1 accessible emission)
- Detector Array:
- High-speed CMOS sensor (120 fps @ 1024×1024)
- Working Distance:
- 15–30 mm non-contact optical aperture
- Housing & Enclosure:
- Titanium Grade 5 (Ti-6Al-4V) hermetic IPX8 body
- Electrical Safety:
- IEC 60601-1 Type BF applied part, IEC 60825-1
Design & Verification Methodology:
Optical Monte Carlo simulation for light transport through human cortical brain tissue; ambient surgical theatre light filtering via narrow bandpass optical coating.
Critical Quality & Verification Failure Modes:
- Laser diode optical power thermal drift causing false capillary perfusion baseline shifts
- Condensation inside optical chamber during rapid autoclave or low-temp sterilization cycles
- Motion artifact degradation during microscopic vessel manipulation
03
Regulatory & Quality Enforcement Pulse
CDRH warning letters and recalls with preventive root causes.
Z-3247-2026 Class II
20260930 Olympus Corporation of the Americas
Subject: Olympus BiCOAG Hemostasis Probe 7Fr Fixed Pin Connector. Model/Catalog Number: CD-B622LA.
Finding / Failure Mode:
Potential for detachment of ceramic tip due to manufacturing without the designated amount of adhesive.
Preventive Action / QMS Control:
Review CAPA root-cause teardown and update process validation protocol per 21 CFR 820.75 / ISO 13485:2016.
Z-3229-2026 Class II
20260930 Medline Industries, LP
Subject: Medline convenience kits containing Healthmark Instrument Channel Brushes. SINUS PACK DYNJ48258D and Sinus Pack DYNJ48258F.
Finding / Failure Mode:
Kits contain Healthmark Instrument Channel Brushes, which were recalled by the manufacturer due to the potential for a sharp edge/burr on the end of the brush. Potential hazards associated include cut injury/abrasion and infection.
Preventive Action / QMS Control:
Review CAPA root-cause teardown and update process validation protocol per 21 CFR 820.75 / ISO 13485:2016.
Z-3218-2026 Class II
20260930 Midmark Corporation
Subject: Midmark IQvitals Zone, automatically and noninvasively measures systolic and diastolic blood pressure, pulse rate, temperature (temporal), and oxygen saturation (SpO2) for adult and pediatric patients, Model Number: 1-200-03300 with Kit Number: 4-000-0624
Finding / Failure Mode:
A performance issue may result in inaccurate blood pressure readings when the Linear Deflation Method is used.
Preventive Action / QMS Control:
Review CAPA root-cause teardown and update process validation protocol per 21 CFR 820.75 / ISO 13485:2016.
Z-3233-2026 Class II
20260930 Philips North America Llc
Subject: Achieva 3.0T; Model Numbers (REF): 1. 781177, 2. 781277, 3. 781278, 4. 781344, 5. 781345;
Finding / Failure Mode:
A software issue will terminate an examination during the image reconstruction process if the scan parameters are manually adjusted such that reconstruction requirements exceed the available system memory.
Preventive Action / QMS Control:
Enforce IEC 62304 Section 9 anomaly regression test battery across all asynchronous thread boundaries and patch firmware via validated bootloader.
04
Regulatory Horizon & Compliance Deadlines
Upcoming enforcement milestones and standards deadlines.
FDA CDRH Mandatory Transition
Milestone Date: February 2, 2026
FDA QMSR Mandatory Effective Date
Complete replacement of legacy 21 CFR Part 820 Quality System Regulation with the Quality Management System Regulation (QMSR), directly incorporating ISO 13485:2016 and risk management (ISO 14971:2019).
Action Checklist:
Update QMS references, ensure clinical risk management directly feeds CAPA triggers, and conduct mock QSIT-to-QMSR transition audits.
EU Notified Bodies / MDCG Enforcement Milestone
Milestone Date: May 26, 2026
EU MDR Annex I GSPR Post-Market Cybersecurity
Notified bodies enforcing MDCG 2019-16 Rev 1 guidance across Class IIb and Class III active devices, requiring lifetime post-market vulnerability handling and SBOM maintenance.
Action Checklist:
Establish automated continuous vulnerability scanning against NIST NVD for third-party libraries across all CE-marked connected firmware.
FDA CDRH Immediate Compliance
Milestone Date: Active Enforcement
CDRH Premarket Cybersecurity Section 524B Refusal-to-Accept (RTA)
FDA strictly rejecting cyber-device submissions missing machine-readable SBOMs (CycloneDX or SPDX format) or lacking structured coordinated vulnerability disclosure (CVD) programs.
Action Checklist:
Embed machine-readable SBOM exports and automated static analysis into Phase 2 design verification prior to eSTAR compilation.
05
Market Trends & Gaining Market Share
Procedural segment growth, market share shifts, and M&A consolidation.
Growing Segments & Market Share Shifts +34% YoY
Pulsed Field Ablation (PFA) Captures 42% of New Electrophysiology Lab Installs
PFA systems continue outpacing traditional radiofrequency (RF) and cryoablation in European and US high-volume centers. Procedural speed and preservation of esophageal tissue drive adoption, putting pressure on legacy thermal ablation platforms.
Active / Leading Entities:
- Medtronic (PulseSelect/Affera)
- Boston Scientific (FARAPULSE)
- Johnson & Johnson (VARIPULSE)
M&A & Strategic Deals $380M Deal Volume
Strategic Consolidation Accelerates in Catheter Robotics & Smart Navigation
Mid-cap device strategics are aggressively acquiring AI-guided navigation startups to bundle smart sensor catheters with existing capital consoles. Valuations reflect strong premiums for cleared 510(k) platforms with valid CPT billing pathways.
Active / Leading Entities:
- Surgical Robotics Consortia
- Interventional Device Ventures
Workforce & Corporate Moves 1,200+ Open R&D Requisitions
MedTech Talent Shifts from Broad Diagnostics to Focused Interventional Lines
Public filings and corporate reorganizations indicate selective headcount reductions in mature consumable segments paired with rapid hiring for systems engineers skilled in IEC 62304 and premarket cybersecurity (Section 524B).
Public Markets & Valuations +2.8% Weekly MedTech Index
Medical Device Equities Outperform Biotech on Resilient Inpatient Procedure Volumes
The MedTech Index gained 2.8% this week led by structural heart and orthopedic implant manufacturers. Resilient procedure volumes reported across Medicare IPPS data continue buffering valuations against macroeconomic headwinds.
06
Reimbursement & CPT Coding Radar
Payment policy, OPPS pass-through, and CPT tracking.
CPT 0924T Category III Tracking Code Active Carrier Discretion
Percutaneous Transcatheter Tricuspid Valve Replacement (TTVR)
Adoption Impact: Enables centers to establish hospital outpatient claims history ahead of formal Category I conversion. Essential tracking metric for novel structural heart implants.
HCPCS C1834 CMS OPPS Transitional Pass-Through Medicare Additional Payment Active
Bioabsorbable Scaffold with Micro-Textured Drug Elution
Adoption Impact: Reimburses incremental device acquisition cost for participating ambulatory surgery centers and outpatient departments.
07
AI, Software & Cybersecurity in MedTech
CDRH AI/ML authorizations and Section 524B compliance.
Computer Vision & Automated Pathology Screening
FDA CDRH Adds 14 New AI/ML-Enabled Medical Devices to Official Directory
Latest authorizations emphasize Good Machine Learning Practice (GMLP) documentation and rigorous pre-determined change control plans (PCCPs), allowing algorithmic updates within specified performance envelopes without requiring a new 510(k).
Actionable Guidance:
Drafting a PCCP upfront during Phase 2 design controls saves an estimated 6 to 9 months on follow-on software releases.
Section 524B FD&C Act Compliance
Cybersecurity Premarket Refusal to Accept (RTA) Enforcement Remains High
CDRH continues strictly enforcing Software Bill of Materials (SBOM) machine-readable exports and vulnerability disclosure plans for all cyber-device submissions. Incomplete vulnerability management plans remain a primary source of 15-day RTA holds.
Actionable Guidance:
Use automated vulnerability scanners and validated SBOM generators before eSTAR premarket dispatch.
08
MedTech AI, Automation & Tooling Workflows
Field-tested automation architectures, generative prompts, and computational pipelines to accelerate 510(k) preparation, SBOM compliance, and design V&V.
Prompt of the Week: eSTAR Predicate Substantial Equivalence Review Prompt
Application: Ready-to-use LLM prompt for regulatory and biomedical engineers
SYSTEM PROMPT / LLM REVIEW TEMPLATE
Act as a senior FDA CDRH regulatory reviewer. Analyze the comparison between Proposed Device [Insert Name/Specs] and Predicate [K-Number/Name]. Evaluate against 21 CFR 807.87 and FDA 510(k) Substantial Equivalence guidance: 1) Are indications for use identical? If different, do differences alter therapeutic intent? 2) Do technological characteristics raise new questions of safety and effectiveness? 3) Identify all required performance bench testing (biocompatibility ISO 10993, electrical safety IEC 60601-1, software IEC 62304) necessary to establish equivalence. Format response as a concise FDA Deficiency Memo table. Quality & Regulatory Guardrail:
Human-in-the-loop regulatory engineer review required per FDA draft guidance on AI/ML in medical device lifecycle.
Regulatory Affairs Automation ⚡ 20–35 engineering hours per 510(k) submission
AI-Driven 510(k) eSTAR Predicate Gap Analysis
Eliminate 15-day CDRH Refusal-to-Accept (RTA) risk before filing
Modern RA teams are automating substantial equivalence tables by running LLM pipelines across openFDA JSON databases and cleared 510(k) summary PDFs. Automated parsers compare primary indications for use (IFU), energy sources, material biocompatibility endpoints (ISO 10993), and electrical safety citations, highlighting missing performance tests instantly.
Stack / Engine:
Automated Pipeline Steps
- Ingest target device draft IFU and proposed predicate K-numbers
- Auto-extract predicate consensus standards citations from CDRH recognition database
- Generate structured Side-by-Side Equivalence Matrix formatted for FDA eSTAR Section 6
- Flag potential substantial equivalence gaps (e.g. different energy modality, novel patient-contact duration)
Cybersecurity & Software Engineering ⚡ 5–10 hours per software sprint / release cycle
Automated SBOM Vulnerability Triaging for Section 524B
Continuous CVSS vulnerability management for connected firmware
Under FDA Section 524B, submissions missing machine-readable Software Bill of Materials (SBOM) or lacking a vulnerability management plan face automatic RTA. Automated pipelines generate CycloneDX/SPDX manifests on every Git commit, scan NIST NVD databases, and map CVEs against the device threat model to calculate true clinical patient risk.
Stack / Engine:
Automated Pipeline Steps
- Generate machine-readable CycloneDX v1.5 JSON SBOM during build automation
- Run automated CVE correlation against NIST National Vulnerability Database
- Filter false positives: verify whether vulnerable code pathways are reachable in embedded firmware
- Export structured Coordinated Vulnerability Disclosure (CVD) audit trail for FDA submission
R&D Simulation & Testing ⚡ 4–8 weeks of bench fixture fabrication and animal lab time
In Silico Clinical Trials & Model Credibility (ASME V&V 40)
Reduce animal and bench test counts with computational evidence
FDA CDRH actively accepts computational modeling and simulation (CM&S) in lieu of physical testing when verified under ASME V&V 40. Modern interventional engineering teams use scriptable catheter mechanics and FEA/CFD digital twins to evaluate worst-case anatomical geometries before machining physical prototypes.
Stack / Engine:
Automated Pipeline Steps
- Define Question of Interest (QoI) and context of use (COU) per ASME V&V 40
- Run automated parametric simulations across 95th-percentile patient vascular anatomy
- Calculate verification & validation error margins against benchmark physical bench tests
- Compile In Silico Credibility Report directly referenced in 510(k) bench testing section
Actionable Workflow of the Week ⚡ Instant peer-review feedback on draft regulatory strategy
eSTAR Predicate Substantial Equivalence Review Prompt
Ready-to-use LLM prompt for regulatory and biomedical engineers
Use this structured prompt with your internal LLM or Claude/GPT workspace to audit your draft substantial equivalence comparison before submitting to FDA.
Stack / Engine:
Starter Prompt / Pipeline Snippet
Act as a senior FDA CDRH regulatory reviewer. Analyze the comparison between Proposed Device [Insert Name/Specs] and Predicate [K-Number/Name]. Evaluate against 21 CFR 807.87 and FDA 510(k) Substantial Equivalence guidance: 1) Are indications for use identical? If different, do differences alter therapeutic intent? 2) Do technological characteristics raise new questions of safety and effectiveness? 3) Identify all required performance bench testing (biocompatibility ISO 10993, electrical safety IEC 60601-1, software IEC 62304) necessary to establish equivalence. Format response as a concise FDA Deficiency Memo table. 08
10xAnd Tools & Pilots
Accelerate your program with free calculators and pilots.
Free Regulatory Tool Regulatory Affairs & R&D Engineers
PredicateScope
Instant 510(k) Predicate Lineage & Equivalence Scanner
Review cleared predicates, product codes, and review clocks in seconds to build an airtight substantial equivalence comparison.
Explore PredicateScope → Service Line Pilot QA Directors & Regulatory Leads
Remediate 10x
DHF Gap Scan with a Scored Deliverable in 72 Hours
Facing a 483 citation, warning letter, or an impending EU MDR / FDA QMSR audit? We pinpoint documentation deficiencies across design controls with zero guesswork.
Review Remediate Pilot → Free Engineering Tool Catheter & Interventional R&D Teams
Catheter Shaft Calculator
Braid, Coil, Wall Thickness & French Size Simulator
Model shaft deflection, pick counts, and radial burst pressure without manual spreadsheet errors.
Run Shaft Calculator → Free Capital Tool MedTech Founders & CEOs
Federal Funding Routes
Non-Dilutive SBIR, STTR & BARDA Grant Matcher
Screen non-dilutive government funding mechanisms mapped specifically to medical device archetypes and clinical maturity stages.
Find Funding Routes →Weekly Intelligence Digest
Receive the Medical Device Snapshot Weekly
Never miss a clearance trend, warning letter finding, or reimbursement change. Select your role to prioritize the signals that matter directly to your day-to-day work.
- Zero hype: Rooted in public clearance records and SEC / CMS data.
- Role tailored: Filter signals relevant to your regulatory tier or engineering discipline.
- Actionable breakdowns: Preventive measures for recalls and warning letters.
Multi-Channel Syndication
Social Pulse & Broadcast Feed
Weekly signals packaged for rapid social review. Follow our feed on X for daily clearance breakdowns, or catch the 2-minute video teardowns on YouTube.
Medical Device Snapshot (Week of October 5 News) is live. Key signals: • Olympus Corporation of the Americas Class II alert • 47 new 510(k) clearances across cardiovascular & ortho • Pulsed Field Ablation captures 42% of new EP installs • CPT 0924T tracking Full breakdown below 🧵👇
1/ REGULATORY RADAR: FDA clearances were dominated by interventional microcatheters and neuromodulation systems this week. Takeaway: Review clock medians reflect faster eSTAR triage for applicants citing predicates with identical primary indications for use.
2/ SAFETY & ENFORCEMENT: CDRH enforcement focused heavily on manufacturing parameter drift and battery management firmware. Warning Letter reminder: Any change in additive manufacturing sintering parameters triggers a 510(k) review under 21 CFR 807.81(a)(3).
3/ MARKET SHIFTS: Pulsed Field Ablation (PFA) continues its rapid displacement of thermal ablation in high-volume cardiac centers. Key advantage: Faster procedure times and reduced esophageal tissue complication risk drive institutional procurement preference.
4/ REIMBURSEMENT UPDATE: CMS active on CPT 0924T (Category III tracking for percutaneous tricuspid valve replacement). If you're developing novel structural heart tech, tracking early hospital outpatient utilization under Cat III codes is vital for payer coverage.
5/ AI & CYBERSECURITY: FDA's Premarket Cybersecurity (Section 524B) enforcement remains uncompromising. Incomplete SBOMs and lack of a structured vulnerability management plan account for over 40% of preliminary 15-day RTA holds for connected medical devices.
6/ 10xAnd TOOL SPOTLIGHT: Checking predicate history for an upcoming submission? Use PredicateScope (100% free) to trace clearance timelines, product code families, and predicate trees in under 10 seconds: https://10xand.com/predicatescope
7/ Subscribe to the Weekly Medical Device Snapshot: Get curated clearances, warning letter analyses, CPT coding shifts, and market share trends delivered to your inbox every Monday: https://10xand.com/snapshot